The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Nanoparticle and targeted systems for cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Paclitaxel and its formulations
Singla, A. K., Garg, A., & Aggarwal, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00986-3 · Cited by 1,100
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 877
Tumor Regression by Targeted Gene Delivery to the Neovasculature
Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R., & Cheresh, D. A. (2002) · Science · doi:10.1126/science.1070200 · Cited by 858
Fonseca, C., Simões, S., & Gaspar, R. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00212-2 · Cited by 755
Mu, L., & Feng, S. S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00320-6 · Cited by 725
Transport of Molecules, Particles, and Cells in Solid Tumors
Jain, R. K. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.241 · Cited by 691
Mitra, S., Gaur, U., Ghosh, P. C., & Maitra, A. N. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00342-x · Cited by 647
Endothelial proliferation in tumours and normal tissues: Continuous labelling studies
Hobson, B., & Denekamp, J. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.66 · Cited by 565
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Fibronectin controls capillary endothelial cell growth by modulating cell shape.
Ingber, D. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.9.3579 · Cited by 495
Feng, S.-S., & Huang, G. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00364-3 · Cited by 398
In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin–PLGA conjugates
Yoo, H. S., Lee, K. H., Oh, J. E., & Park, T. G. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00280-7 · Cited by 374
Feng, S.-S., & Chien, S. (2003) · Chemical Engineering Science · doi:10.1016/s0009-2509(03)00234-3 · Cited by 364
Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery
Kircheis, R., Kichler, A., Wallner, G., Kursa, M., Ogris, M., Felzmann, T., Buchberger, M., & Wagner, E. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300418 · Cited by 359
Ogris, M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00230-x · Cited by 286
Gaur, U., Sahoo, S. K., De, T. K., Ghosh, P. C., Maitra, A., & Ghosh, P. K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00447-0 · Cited by 267
Blessing, T., Kursa, M., Holzhauser, R., Kircheis, R., & Wagner, E. (2001) · Bioconjugate Chemistry · doi:10.1021/bc0001488 · Cited by 245
Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy
Chari, R. V. J. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00095-1 · Cited by 235
Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer.
Fox, S. B., Gatter, K. C., Bicknell, R., Going, J. J., Stanton, P. D., Cooke, T. G., & Harris, A. L. (1993) · PubMed · Cited by 210
Ogris, M., Steinlein, P., Carotta, S., Brunner, S., & Wagner, E. (2001) · AAPS PharmSci · doi:10.1208/ps030321 · Cited by 209
Nielsen, U. B., Kirpotin, D. B., Pickering, E. M., Hong, K., Park, J. W., Refaat Shalaby, M., Shao, Y., Benz, C. C., & Marks, J. D. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00256-2 · Cited by 177
Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects
Lu, Y. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00215-3 · Cited by 172
Successful Treatment of an Angiogenic Disease
Folkman, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201811 · Cited by 162
Renaissance of cancer therapeutic antibodies
Glennie, M. J., & van de Winkel, J. G. J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02714-4 · Cited by 155
Toward Selection of Internalizing Antibodies from Phage Libraries
Becerril, B., Poul, M., & Marks, J. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0177 · Cited by 147
Tumour vasculature as a target for anticancer therapy
Eatock, M. M., Schätzlein, A. G., & Kaye, S. B. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0158 · Cited by 139
Exploiting the hallmarks of cancer
Sledge, G. W., & Miller, K. D. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00273-9 · Cited by 138
Shikata, F., Tokumitsu, H., Ichikawa, H., & Fukumori, Y. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00198-9 · Cited by 122
VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies
Dagar, S., Krishnadas, A., Rubinstein, I., Blend, M. J., & Onyüksel, H. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00242-6 · Cited by 119
Wang, Y. M., Sato, H., Adachi, I., & Horikoshi, I. (1996) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.44.1935 · Cited by 113
An overview of targeted treatments in cancer
Abou-Jawde, R. M., Choueiri, T. K., Alemany, C. A., & Mekhail, T. M. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80209-6 · Cited by 102
New developments in angiogenesis: a major mechanism for tumor growth and target for therapy.
Jones, A., & Harris, A. L. (1998) · PubMed · Cited by 83
Nanoparticle-mediated gene delivery to tumour neovasculature
Reynolds, A. R., Moghimi, S. M., & Hodivala‐Dilke, K. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)00004-7 · Cited by 57
Suzawa, T. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00554-5 · Cited by 51
Targeting Tumor Angiogenesis with Gene Therapy
Chen, Q., Zhang, L. J., Gasper, W. J., & Mixson, A. J. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3223 · Cited by 48
Rodolfo, M., Melani, C. C., Zilocchi, C., Cappetti, B., Luison, E., Arioli, I., Parenza, M., Canevari, S., & Colombo, M. P. (1998) · PubMed · Cited by 42
Kim, I., & Kim, S. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00128-5 · Cited by 41
Research works printed but not linked: 4
- Grossfeld, 2002, Thrombospondin-1 expression in patients with pathologic state T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis and tumor progression, Urology, 59, 97, 10.1016/S0090-4295(01)01476-5 · doi:10.1016/s0090-4295(01)01476-5
- Teicher, 2000, Molecular targets and cancer therapeutics: discovery, development and clinical validation, Drug Resistance Updates, 3, 67, 10.1054/drup.2000.0123 · doi:10.1054/drup.2000.0123
- Sepp, 1997, Endothelial cells and angiogenesis, Experimental Dermatology, 6, 272, 10.1111/j.1600-0625.1997.tb00172.x · doi:10.1111/j.1600-0625.1997.tb00172.x
- Williams, 2003, Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors, Journal of Controlled Release, 91, 167, 10.1016/S0168-3659(03)00241-4 · doi:10.1016/s0168-3659(03)00241-4
Cited by
Gold nanoparticles in delivery applications☆
GHOSH, P., HAN, G., DE, M., KIM, C., & ROTELLO, V (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.016 · Cited by 2,694
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Cell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Applications of Nanoparticles in Biology
De, M., Ghosh, P. S., & Rotello, V. M. (2008) · Advanced Materials · doi:10.1002/adma.200703183 · Cited by 1,547
Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles
Laurent, S., Dutz, S., Häfeli, U. O., & Mahmoudi, M. (2011) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2011.04.003 · Cited by 1,326
Metadata
- Authors
- Brannon-Peppas, L., & Blanchette, J. O.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 56
- Issue
- 11
- Pages
- 1649-1659
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2095248480
- Cited by
- 2,334
- References
- 39
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.